A Study of Acalabrutinib Plus Venetoclax and Rituximab in Participants With Treatment Na ïve Mantle Cell Lymphoma
Condition: Mantle Cell Lymphoma (MCL) Interventions: Drug: Acalabrutinib; Drug: Venetoclax; Drug: Rituximab Sponsor: AstraZeneca Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials